Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Suppression of ischemic and reperfusion ventricular arrhythmias by inhalational anesthetic-induced preconditioning in the rat heart

Ríha H, Neckář J, Papoušek F, Netuka I, Pirk J, Kolář F, Ošťádal B.

. 2011 ; 60 (4) : 709-714.

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11037191

Inhalational anesthetic-induced preconditioning (APC) has been shown to reduce infarct size and attenuate contractile dysfunction caused by myocardial ischemia. Only a few studies have reported the effects of APC on arrhythmias during myocardial ischemia-reperfusion injury, focusing exclusively on reperfusion. Accordingly, the aim of the present study was to examine the influence of APC on ventricular arrhythmias evoked by regional no-flow ischemia. APC was induced in adult male Wistar rats by 12-min exposures to two different concentrations (0.5 and 1.0 MAC) of isoflurane followed by 30-min wash-out periods. Ventricular arrhythmias were assessed in the isolated perfused hearts during a 45-min regional ischemia and a subsequent 15-min reperfusion. Myocardial infarct size was determined after an additional 45 min of reperfusion. The incidence, severity and duration of ventricular arrhythmias during ischemia were markedly reduced by APC. The higher concentration of isoflurane had a larger effect on the incidence of ventricular fibrillation than the lower concentration. The incidence of ventricular tachycardia and reversible ventricular fibrillation during reperfusion was also significantly reduced by APC; the same was true for myocardial infarct size. In conclusion, we have shown that preconditioning with isoflurane confers profound protection against myocardial ischemia- and reperfusion-induced arrhythmias and lethal myocardial injury.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 21

000      
00000naa 2200000 a 4500
001      
bmc11037191
003      
CZ-PrNML
005      
20120731160550.0
008      
111013s2011 xr e eng||
009      
AR
024    7_
$a 10.33549/physiolres.932137 $2 doi
035    __
$a (PubMed)21916525
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Říha, Hynek. $7 xx0185812
245    10
$a Suppression of ischemic and reperfusion ventricular arrhythmias by inhalational anesthetic-induced preconditioning in the rat heart / $c Ríha H, Neckář J, Papoušek F, Netuka I, Pirk J, Kolář F, Ošťádal B.
314    __
$a Department of Anesthesiology and Intensive Care Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. hynek.riha@ikem.cz
504    __
$a Lit.: 21
520    9_
$a Inhalational anesthetic-induced preconditioning (APC) has been shown to reduce infarct size and attenuate contractile dysfunction caused by myocardial ischemia. Only a few studies have reported the effects of APC on arrhythmias during myocardial ischemia-reperfusion injury, focusing exclusively on reperfusion. Accordingly, the aim of the present study was to examine the influence of APC on ventricular arrhythmias evoked by regional no-flow ischemia. APC was induced in adult male Wistar rats by 12-min exposures to two different concentrations (0.5 and 1.0 MAC) of isoflurane followed by 30-min wash-out periods. Ventricular arrhythmias were assessed in the isolated perfused hearts during a 45-min regional ischemia and a subsequent 15-min reperfusion. Myocardial infarct size was determined after an additional 45 min of reperfusion. The incidence, severity and duration of ventricular arrhythmias during ischemia were markedly reduced by APC. The higher concentration of isoflurane had a larger effect on the incidence of ventricular fibrillation than the lower concentration. The incidence of ventricular tachycardia and reversible ventricular fibrillation during reperfusion was also significantly reduced by APC; the same was true for myocardial infarct size. In conclusion, we have shown that preconditioning with isoflurane confers profound protection against myocardial ischemia- and reperfusion-induced arrhythmias and lethal myocardial injury.
650    _2
$a anestetika inhalační $x aplikace a dávkování $7 D018685
650    _2
$a zvířata $7 D000818
650    _2
$a srdce $x patofyziologie $x účinky léků $7 D006321
650    _2
$a ischemické přivykání $x metody $7 D019157
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ischemická choroba srdeční $x farmakoterapie $x patofyziologie $7 D017202
650    _2
$a reperfuzní poškození myokardu $x farmakoterapie $x patofyziologie $7 D015428
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a fibrilace komor $x farmakoterapie $x patofyziologie $7 D014693
655    _2
$a srovnávací studie $7 D003160
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Neckář, Jan, $d 1973- $7 xx0074182
700    1_
$a Papoušek, František, $d 1948- $7 xx0074150
700    1_
$a Netuka, Ivan, $d 1973- $7 xx0074183
700    1_
$a Pirk, Jan, $d 1948- $7 nlk19990073700
700    1_
$a Kolář, František, $d 1952 říjen 2.- $7 xx0037264
700    1_
$a Ošťádal, Bohuslav, $d 1940- $7 nlk19990073642
773    0_
$w MED00003824 $t Physiological research $g Roč. 60, č. 4 (2011), s. 709-714 $x 0862-8408
856    41
$u http://www.biomed.cas.cz/physiolres/pdf/60/60_709.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 2
990    __
$a 20111013094714 $b ABA008
991    __
$a 20120731160634 $b ABA008
999    __
$a ok $b bmc $g 883163 $s 747364
BAS    __
$a 3
BMC    __
$a 2011 $b 60 $c 4 $d 709-714 $m Physiological research $x MED00003824
LZP    __
$a 2011-20/mkme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé